Bavarian Nordic is known for its innovative smallpox and monkeypox vaccine, IMVANEX® (also known as JYNNEOS® in the U.S.

Bavarian Nordic is known for its innovative smallpox and monkeypox vaccine, IMVANEX® (also known as JYNNEOS® in the U.S. and IMVAMUNE® in Canada). This non replicating vaccine is approved for use in multiple countries and is a crucial tool in global efforts to combat these diseases.Ebola Vaccine: The company is developing an Ebola vaccine based on its MVA−BN® technology platform, which has shown promise in preclinical and clinical studies.A therapeutic cancer vaccine candidate designed to treat prostate cancer. PROSTVAC® has been evaluated in numerous clinical trials and is a key component of Bavarian Nordic’s oncology pipeline. An immunotherapy targeting the brachyury protein, which is associated with tumor metastasis. This innovative approach aims to improve outcomes for patients with metastatic cancer.